PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Microbiome: Expanding the Gut Gene Catalog
November 2014
Complex Search
September 2014
Repairing a Rift
September 2014
iTRAQing the Ubiquitinome
July 2014
Immunity: Clustering Immunoglobulins
June 2014
Mining Protein Dynamics
May 2014
Design and Discovery: Identifying New Enzymes and Metabolic Pathways
January 2014
Epigenetics: Tracing Histone Demethylase Inhibitors
December 2013
Cancer Networks: Predicting Catalytic Residues from 3D Protein Structures
November 2013
Protein-Nucleic Acid Interaction: Inhibition Through Allostery
July 2013
Infectious Diseases: Targeting Meningitis
May 2013
Protein Interaction Networks: Reading Between the Lines
April 2013
Design and Discovery: A Cocktail for Proteins Without ID
February 2013
Targeting Enzyme Function with Structural Genomics
July 2012
More in one
June 2012
Disordered Proteins
February 2012
RNA Chaperone NMB1681
July 2011
Capsid assembly in motion
April 2011
One at a time
April 2011
A growing family
February 2011
Predicting functions within a superfamily
January 2011
Isoxanthopterin Deaminase
November 2010
Scaling up mutational scanning
November 2010
Alpha/Beta Barrels
October 2010
Mre11 Nuclease
May 2010
Assigning protein function: GeMMA
April 2010
Face off
October 2009

Technology Topics Annotation/Function

Design and Discovery: Identifying New Enzymes and Metabolic Pathways

SBKB [doi:10.1038/sbkb.2012.179]
Featured Article - January 2014
Short description: Homology modeling and metabolite docking predict in vitro enzymatic activities and physiological functions.

The binding site of the model of HpbJ with the top-ranked ligand tHyp-B (purple) docked. 1

While the annotation of large-scale sequencing projects can often predict the function of uncharacterized proteins based on sequence homology, those predictions are prone to errors; thus, assigning valid function based on homology alone remains a challenge. To demonstrate the utility of computation-guided approaches to the prediction of enzymatic function, Jacobson and colleagues (PSI NYSGRC) developed a structure-guided strategy to discover a previously undocumented activity, 4R-hydroxyproline betaine 2-epimerase (Hyp-B 2-epimerase), and the associated catabolic pathway by which trans-4-hydroxy-L-proline-betaine (tHyp-b) is converted to α-ketoglutarate.

As a starting point, the authors used the structure of an uncharacterized member of the enolase superfamily, HpbD from marine bacterium Pelagibaca bermudensis, solved as part of the NYSGRC's efforts (PDB 2PMQ). A library of ∼87,000 ligands, including metabolites and potential enolase substrates, was used for in silico docking to HpbD's active site. The top scoring hits, as ranked by calculated binding affinities, contained several proline analogs, leading to the prediction that the enzyme was an amino acid racemase or epimerase.

Because bacterial genes encoding proteins in the same metabolic pathway are often clustered, the authors carried out homology modeling of an ABC-type transporter encoded by hpbJ, a gene located next to hpdD that had been previously annotated as binding glycine betaine or L-proline. The HpbJ model indicated that its ligand was indeed likely a betaine, and virtual docking of a library of betaines ranked tHyp-B as having the highest affinity. Modeling of a protein encoded by another hpbD neighbor—HpbB1— also predicted a betaine substrate.

Collectively, these results suggested a pathway in which HpbD uses tHyp-B as substrate in a 1,1-proton transfer (epimerase) reaction. The authors verified this prediction with enzymatic analyses and by solving the structure of HpbD bound to tHyp-B (PDB 4H2H). They further speculated that these proteins might constitute a catabolic pathway that degrades tHyp-B to α-ketoglutarate, with HpbD catalyzing the first reaction: epimerization of tHyp-B to cHyp-B.

Using gene deletions, the authors carried out functional analyses of the hpbD gene cluster in Paracoccus denitrificans and demonstrated that the proteins are part of a pathway that controls the intracellular concentration of tHyp-B. Under low salt growth conditions, tHyp-B was used as a carbon source, in a catabolic pathway beginning with the epimerization of tHyp-B and culminating in the production of α-ketoglutarate. In contrast, under high salt conditions, the pathway was inactivated, allowing for the accumulation of tHyp-B, which then acted as an osmoprotectant. The expression of HpbD was downregulated under high salt conditions, and this mode of regulation could serve as an osmolarity-dependent switch that determines either the accumulation of tHyp-B or its utilization as an alternative carbon and nitrogen source.

Stéphane Larochelle

References

  1. S. Zhao et al. Discovery of new enzymes and metabolic pathways by using structure and genome context.
    Nature. 502, 698-702 (2013). doi:10.1038/nature12576

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health